Verde Bio EBITDA margin
Was ist das EBITDA margin von Verde Bio?
EBITDA margin von Verde Bio Holdings, Inc. ist -342.66%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Finance Sektor auf OTC im Vergleich zu Verde Bio
Was macht Verde Bio?
Verde Bio Holdings, Inc. engages in the oil and gas exploration and investment business. It has mineral and royalty interests in various properties. The company was formerly known as Appiphany Technologies Holdings Corp. and changed its name to Verde Bio Holdings, Inc. in May 2020. Verde Bio Holdings, Inc. was incorporated in 2010 and is based in Frisco, Texas.
Unternehmen mit ebitda margin ähnlich Verde Bio
- Exicure hat EBITDA margin von -343.51%
- Exicure hat EBITDA margin von -343.51%
- AdAlta hat EBITDA margin von -343.26%
- Golden Valley Mines hat EBITDA margin von -343.06%
- Golden Valley Mines hat EBITDA margin von -343.06%
- Endexx hat EBITDA margin von -342.80%
- Verde Bio hat EBITDA margin von -342.66%
- Keyne Ltd hat EBITDA margin von -342.52%
- Newfield Resources hat EBITDA margin von -342.47%
- Genomic Vision Societe Anonyme hat EBITDA margin von -342.13%
- Génomic Vision SA hat EBITDA margin von -342.13%
- Remark Inc hat EBITDA margin von -341.55%
- Versus Systems hat EBITDA margin von -341.28%